medigraphic.com
Colegio de Medicina Interna de México.

2021, Number 5

<< Back Next >>

Med Int Mex 2021; 37 (5)

Telogen effluvium and alopecia areata: associated symptoms in patients with long COVID-19

Guillén-Ortega FC

Language: Spanish
References: 23
Page: 716-720
PDF size: 244.61 Kb.


ABSTRACT

Background: SARS-CoV-2 mainly attacks the respiratory system, but as more has become known about the virus, other organs have also been affected. As time passes, new symptoms emerge, no longer in the water phase, now in the recovery stage in what has been called long COVID or persistent COVID.
Objective: To communicate one more of the symptoms of patients with long COVID- 19.
Materials and Methods: A case series study was done from October 1st 2020 to March 31st 2021 at Neumology consultation of a private medical center at Chiapas, Mexico, including patients that had recurrently reported hair loss of unexplained cause after the SARS-CoV-2 infection.
Results: Information was collected from 28 patients, 16 men and 12 women, the hair loss began one month after the infection and in 5/28 it persisted for more than 6 months.
Conclusions: Having a series of cases where all have in common having been infected by SARS-CoV-2, the association is impossible, so these alterations of the hair follicle can be caused by SARS-CoV-2 and should be included to the long list of symptoms that occur in this entity.


REFERENCES

  1. Paus R, Peker S, Sundberg JP. Biology of hair and nails. En: Bolognia JL, Jorizzo JL, Rapini RP. Dermatology textbook, 2nd ed. Londres, Mosby Elsevier, 2008; 965-1073.

  2. Paus R. Control of the hair cycle and hair diseases as cycling disorders. Curr Opin Dermatol 1996; 3: 248-258.

  3. Stenn KS, Combates NJ, Eilertsen KJ. Hair follicle growth controls. Dermatol Clin 1996; 14: 543-558.

  4. Kligman AM. Pathologic dynamics of human hair loss: telogen effluvium. Arch Dermatol 1961; 83: 175-198. doi:10.1001/archderm.1961.01580080005001.

  5. Tosti A, Bardazzi F, Guerra L. Alopecia areata and thyroid function in children. J Am Acad Dermatol 1988; 19: 1118- 1119. https://doi.org/10.1016/S0190-9622(98)80009-1.

  6. Happle R, Van der Steen PH, Pret C. The Renbök phenomenon: an inverse Köbner reaction observed in alopecia areata. Eur J Dermatol 1991; 3: 228-230.

  7. Blaumeiser B, Van der Goot I, Fimmers R, Hanneken S, et al. Familial aggregation of alopecia areata. J Am Acad Dermatol 2006; 54: 627-632. doi: 10.1016/j.jaad.2005.12.007.

  8. Shah W, Hillman T, Playford ED, Hishmeh L. Managing the long-term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ 2021; 372: n136. doi:10.1136/ bmj.n136.

  9. Guerra-Tapia A, González-Guerra E, de la Cruz-Bertolo J. Alopecia femenina y sistemas de integración capilar: estudio de la repercusión psicológica. Med Cutan Iber Lat Am 2012; 40 (4): 103-108. DOI:10.4464/MD.2012.40.4.5024.

  10. COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. Available at https://www.covid19treatmentguidelines. nih.gov/.

  11. Carpio-Orantes LD, García-Mendez S, Sánchez-Díaz JS, Peniche-Moguel KG, et al. Dermatological manifestations in patients with COVID-19 pneumonia in Veracruz, Mexico. Dermatol Arch 2020; 4 (1): 112-114.

  12. Carrillo-Esper R, Carrillo-Córdova JR, Carrillo-Córdova LD. Efluvio de telógeno. Med Int Mex 2011; 27 (3): 294-298.

  13. Bernstein GM, Crollick JS, Hassett JM Jr. Postfebrile telogen effluvium in critically ill patients. Crit Care Med 1988; 16: 98-99. doi: 10.1097/00003246-198801000-00020.

  14. Chu C-B, Yang CC. Dengue-associated telogen effluvium: a report of 14 patients. Dermatologica Sinica 2017; 35 (3): 124-126. https://doi.org/10.1016/j.dsi.2017.03.005.

  15. Rizzetto G, Diotallevi F, Campanati A, Radi G, et al. Telogen effluvium related to post severe Sars-Cov-2 infection: Clinical aspects and our management experience. Dermatol Ther 2021; 34: e14547. doi.org/10.1111/dth.14547.

  16. Ye Q, Wang B, Mao J. The pathogenesis and treatment of the cytokine storm' in COVID-19. J Infection 2020; 80 (6): 607-613. doi.org/10.1016/j.jinf.2020.03.037.

  17. Garg S, Garg M, Prabhakar N, Malhotra P, Agarwal R. Unraveling the mystery of Covid-19 cytokine storm: from skin to organ systems. Dermatol Ther 2020; e13859. https:// doi.org/10.1111/dth.13859.

  18. Diotallevi F, Campanati A, Bianchelli T, Bobyr I, et al. Skin involvement in SARS-CoV-2 infection: case series. J Med Virol 2020; 92: 2332-2334. doi: 10.1002/jmv.26012.

  19. Headington JT. Telogen effluvium. New concepts and review. Arch Dermatol 1993; 129 (3): 356-363. doi: 10.1001/ archderm.129.3.356.

  20. Cash TF, Price VH, Savin RC. Psychological effects of androgenetic alopecia on women: comparisons with balding men and with female control subjects. J Am Acad Dermatol 1993; 29: 568-75. doi: 10.1016/0190-9622(93)70223-g.

  21. Hunt N, McHale S. Understanding alopecia. London, United Kingdom: Sheldon, 2004; 1218.

  22. York J, Nicholson T, Minors P, Duncan DF. Stressful life events and loss of hair among adult women, a case-control study. Psychol Rep 1998; 82 (3 Pt 1): 1044-6. doi: 10.2466/ pr0.1998.82.3.1044.

  23. Hunt N, McHale S. The psychological impact of alopecia. BMJ 2005; 331: 951-3. doi: 10.1136/bmj.331.7522.951.




2020     |     www.medigraphic.com